News
Alchemab Therapeutics reveals Alzheimer’s candidate
Alchemab Therapeutics – a company focusing naturally occurring antibodies – has announced data relating to its ATLX-1088.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Alchemab Therapeutics – a company focusing naturally occurring antibodies – has announced data relating to its ATLX-1088.